Source: Annual Congress 2005 - Immunology in interstitial lung disease and airway infectious problems
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Chandra, F. Al-Ghanmi, D. S. Kumararatne, A. M. Condliffe (Cambridge, United Kingdom). Granulomatous lung disease in common variable immunodeficiency: practical issues and difficulties in diagnosis and management. Eur Respir J 2005; 26: Suppl. 49, 2421

Member's Comments

No comment yet.

Related content which might interest you: Rare lung diseases in children: challenges for diagnosis and treatment Source: Virtual Congress 2021 – Rare lung diseases 2021 Year: 2021 Severe sarcoidosis: clinical features and management Source: Virtual Congress 2021 – Rare lung diseases 2021 Year: 2021 How could we objectively measure lung disease severity in children with severe combined immunodeficiency? Source: Annual Congress 2005 - New insights in respiratory infections in children Year: 2005 Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Lung manifestations of chronic granulomatous disease; a clinical survey of patients from the Iranian primary immunodeficiency registry Source: Eur Respir J 2001; 18: Suppl. 33, 510s Year: 2001 Multidisciplinary approach to systemic diseases: benefits for diagnosis and management of complex disorders Source: Eur Respir Monogr 2019; 86: 1-13 Year: 2019 Differential diagnosis of granulomatous lung disease: clues and pitfalls Source: Eur Respir Rev, 26 (145) 170012; 10.1183/16000617.0012-2017 Year: 2017 Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need Source: Breathe, 16 (3) 200066; 10.1183/20734735.0066-2020 Year: 2020 Interstitial lung disease in common variable immunodeficiency associated granulomatous disease Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Interstitial pneumonia with autoimmune features: challenges and controversies Source: Eur Respir Rev, 30 (162) 210177; 10.1183/16000617.0177-2021 Year: 2021 A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease Source: Eur Respir J, 58 (6) 2100276; 10.1183/13993003.00276-2021 Year: 2021 Differential diagnosis of bilateral pneumonia: major issues Source: Eur Respir J 2001; 18: Suppl. 33, 464s Year: 2001 Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021 Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management Source: Guideline 2016 Year: 2016 Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management Source: Eur Respir J 2016; 47: 45-68 Year: 2016 Immunodeficiencies in adulthood: lung disease manifestations and treatment options Source: International Congress 2019 – PG6 Immunodeficiencies in lung diseases Year: 2019 Imaging of idiopathic pulmonary fibrosis based on case presentations: guidelines, pitfalls and prevention of misdiagnosis Source: Virtual Congress 2021 – Imaging grand round Year: 2021 Current challenges in diagnosing and treating adults with interstitial lung disease Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease Year: 2014 Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 Diagnosis of interstitial lung diseases and impact of guidelines: an issue only for pulmonologists? Source: Annual Congress 2007 - Controversies in the management of interstitial lung diseases Year: 2007